Related Experiment Video
Updated: Jan 16, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
Mitigating Methotrexate-Induced Kidney Damage in Mice by the Phragmanthera austroarabica Extract, Its Major
Dina M Hal1, Eman T Mehanna2, Reem M Hazem3
1Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
Abstract:
Phragmanthera austroarabica is known for its antioxidant and anti-inflammatory properties due to its high polyphenol content. Its chemical profile, analyzed via LC-ESI-TOF-MS/MS, revealed 28 compounds, including flavonoids, phenolics, and terpenes. This study examined the protective effects of the P. austroarabica crude extract, its major constituent gallic acid, and its polymeric nanoparticles (NPs) against methotrexate (MTX)-induced kidney toxicity in mice. Polymeric NPs were prepared using the nanoprecipitation technique to enhance efficacy. Kidney injury was induced by a single intraperitoneal dose of MTX (20 mg/kg), and mice were divided into six groups: control, MTX, and four cotreatment groups receiving MTX with the P. austroarabica extract, its NPs, gallic acid, or gallic acid NPs. The treatments lasted 10 days, starting 5 days before MTX injection. The extract, gallic acid, and their NPs improved renal function, inhibited MTX-induced renal tissue damage, reduced oxidative stress, enhanced antioxidant defenses (Nrf2/HO-1 upregulation), suppressed inflammation (downregulation of NF-κB, NLRP3, caspase-1, IL-1β, IL-6, and TNF-α and an increase in PPARγ), and prevented apoptosis (decreased Bax and caspase-3 and increased Bcl-2). These findings suggest that P. austroarabica and gallic acid NPs may serve as potential protective agents against MTX-induced nephrotoxicity.
More Related Videos
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Therapeutic Drug Monitoring: Affecting Factors